Progyny (PGNY) Asset Writedowns and Impairment (2018 - 2026)

Progyny (PGNY) has reported Asset Writedowns and Impairment for 9 consecutive years, with $4.4 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Asset Writedowns and Impairment fell 21.61% year-over-year to $4.4 million; the TTM figure through Mar 2026 stood at $19.3 million (up 11.69% YoY), while the FY2025 annual figure was $20.5 million, up 25.19% from the prior year.
• Asset Writedowns and Impairment eased to $4.4 million in Q1 2026 per PGNY's latest filing, from $5.2 million in the prior quarter.
• Across five years, Asset Writedowns and Impairment topped out at $5.7 million in Q1 2025 and bottomed at $2.3 million in Q1 2022.
• Historically, Asset Writedowns and Impairment has averaged $4.4 million across 5 years, with a median of $4.6 million in 2023.
• Annual changes were most pronounced in 2023 — Asset Writedowns and Impairment jumped 129.9% — and 2024, when it sank 39.98%.
• Progyny's Asset Writedowns and Impairment stood at $4.1 million in 2022, then rose by 18.57% to $4.9 million in 2023, then dropped by 24.84% to $3.7 million in 2024, then soared by 41.48% to $5.2 million in 2025, then declined by 14.38% to $4.4 million in 2026.
• Business Quant data shows PGNY's Asset Writedowns and Impairment at $4.4 million in Q1 2026, $5.2 million in Q4 2025, and $4.3 million in Q3 2025.